Sodium 4-phenylbutyrate Basic information |
Product Name: | Sodium 4-phenylbutyrate |
Synonyms: | SPB;SODIUM 4-PHENYLBUTYRATE;SODIUM PHENYLBUTYRATE;PBNA;PHENYL N-BUTYRATE SODIUM SALT;4-PHENYLBUTYRATE, NA;4-PHENYLBUTYRIC ACID SODIUM;4-PHENYLBUTYRIC ACID SODIUM SALT |
CAS: | 1716-12-7 |
MF: | C10H11NaO2 |
MW: | 186.18 |
EINECS: | 605-612-7 |
Product Categories: | VASOTEC |
Mol File: | 1716-12-7.mol |
![]() |
Sodium 4-phenylbutyrate Chemical Properties |
storage temp. | Desiccate at -20°C |
solubility | H2O: ≥5mg/mL |
form | White to slightly yellow solid |
color | white to beige |
InChIKey | OBKXEAXTFZPCHS-UHFFFAOYSA-N |
CAS DataBase Reference | 1716-12-7(CAS DataBase Reference) |
Safety Information |
Hazard Codes | Xi |
Risk Statements | 36 |
Safety Statements | 26 |
WGK Germany | 3 |
RTECS | CY9057220 |
HS Code | 29163990 |
Sodium 4-phenylbutyrate Usage And Synthesis |
Chemical Properties | White or yellowish-white powder. |
Uses | ACE inhibitor, antihypertensive |
Definition | ChEBI: The organic sodium salt of 4-phenylbutyric acid. A prodrug for phenylacetate, it is used to treat urea cycle disorders. |
Brand name | Buphenyl (Medicis). |
Biological Activity | Histone deacetylase inhibitor that displays anticancer activity. Inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. Also inhibits protein isoprenylation, depletes plasma glutamine, increases production of fetal hemoglobin through transcriptional activation of the γ -globin gene and affects hPPAR γ activation. |
Sodium 4-phenylbutyrate Preparation Products And Raw materials |
L-LYSINE L-MALATE Preparation Products And Raw materials |